Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

BioMed Research International
Volume 2015 (2015), Article ID 714230, 16 pages
http://dx.doi.org/10.1155/2015/714230
Research Article

Effect of Short-Term Stimulation with Interleukin-1β and Differentiation Medium on Human Mesenchymal Stromal Cell Paracrine Activity in Coculture with Osteoblasts

1AO Research Institute Davos, 7270 Davos Platz, Switzerland
2Department of Oral and Maxillofacial Surgery/Clinical Navigation, Charité-Universitätsmedizin Berlin, Campus Virchow-Clinic, 13353 Berlin, Germany
3Department of Oral and Maxillofacial Surgery, Medical Center-University of Freiburg, 79106 Freiburg, Germany

Received 4 August 2015; Revised 10 November 2015; Accepted 26 November 2015

Academic Editor: Limei Qiu

Copyright © 2015 Jan O. Voss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Silber, D. G. Anderson, S. D. Daffner et al., “Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion,” Spine, vol. 28, no. 2, pp. 134–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. E. M. Younger and M. W. Chapman, “Morbidity at bone graft donor sites,” Journal of Orthopaedic Trauma, vol. 3, no. 3, pp. 192–195, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. A. R. Amini, C. T. Laurencin, and S. P. Nukavarapu, “Bone tissue engineering: recent advances and challenges,” Critical Reviews in Biomedical Engineering, vol. 40, no. 5, pp. 363–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Zhukareva, M. Obrocka, J. D. Houle, I. Fischer, and B. Neuhuber, “Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli,” Cytokine, vol. 50, no. 3, pp. 317–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. A. Einhorn, “The cell and molecular biology of fracture healing,” Clinical Orthopaedics and Related Research, no. 355, supplement, pp. S7–S21, 1998. View at Google Scholar · View at Scopus
  7. P. Kolar, K. Schmidt-Bleek, H. Schell et al., “The early fracture hematoma and its potential role in fracture healing,” Tissue Engineering—Part B: Reviews, vol. 16, no. 4, pp. 427–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kolar, T. Gaber, C. Perka, G. N. Duda, and F. Buttgereit, “Human early fracture hematoma is characterized by inflammation and hypoxia,” Clinical Orthopaedics and Related Research, vol. 469, no. 11, pp. 3118–3126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Schmidt-Bleek, H. Schell, N. Schulz et al., “Inflammatory phase of bone healing initiates the regenerative healing cascade,” Cell and Tissue Research, vol. 347, no. 3, pp. 567–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Einhorn, R. J. Majeska, E. B. Rush, P. M. Levine, and M. C. Horowitz, “The expression of cytokine activity by fracture callus,” Journal of Bone and Mineral Research, vol. 10, no. 8, pp. 1272–1281, 1995. View at Google Scholar · View at Scopus
  11. L. C. Gerstenfeld, T.-J. Cho, T. Kon et al., “Impaired fracture healing in the absence of TNF-α signaling: the role of TNF-α in endochondral cartilage resorption,” Journal of Bone and Mineral Research, vol. 18, no. 9, pp. 1584–1592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Ding, O. Ghali, P. Lencel et al., “TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells,” Life Sciences, vol. 84, no. 15-16, pp. 499–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. B. Evans, R. A. D. Bunning, J. Van Damme, and R. G. G. Russell, “Natural human IL-1β exhibits regulatory actions on human bone-derived cells invitro,” Biochemical and Biophysical Research Communications, vol. 159, no. 3, pp. 1242–1248, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Gowen, D. D. Wood, E. J. Ihrie, M. K. McGuire, and R. G. Russell, “An interleukin 1 like factor stimulates bone resorption in vitro,” Nature, vol. 306, no. 5941, pp. 378–380, 1983. View at Publisher · View at Google Scholar
  15. T. Nakase, K. Takaoka, K. Masuhara, K. Shimizu, H. Yoshikawa, and T. Ochi, “Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells,” Bone, vol. 21, no. 1, pp. 17–21, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. L. C. Gerstenfeld, D. M. Cullinane, G. L. Barnes, D. T. Graves, and T. A. Einhorn, “Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation,” Journal of Cellular Biochemistry, vol. 88, no. 5, pp. 873–884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Kon, T.-J. Cho, T. Aizawa et al., “Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing,” Journal of Bone and Mineral Research, vol. 16, no. 6, pp. 1004–1014, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Lange, A. Sapozhnikova, C. Lu et al., “Action of IL-1beta during fracture healing,” Journal of Orthopaedic Research, vol. 28, no. 6, pp. 778–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Ferreira, R. M. Porter, N. Wehling et al., “Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow,” The Journal of Biological Chemistry, vol. 288, no. 41, pp. 29494–29505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Loebel, E. M. Czekanska, J. Staudacher et al., “The calcification potential of human MSCs can be enhanced by interleukin-1β in osteogenic medium,” Journal of Tissue Engineering and Regenerative Medicine, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Mumme, C. Scotti, A. Papadimitropoulos et al., “Interleukin-1beta modulates endochondral ossification by human adult bone marrow stromal cells,” European Cells & Materials, vol. 24, pp. 224–236, 2012. View at Google Scholar · View at Scopus
  22. K. Sonomoto, K. Yamaoka, K. Oshita et al., “Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway,” Arthritis & Rheumatism, vol. 64, no. 10, pp. 3355–3363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Overman, E. Farré-Guasch, M. N. Helder, C. M. Ten Bruggenkate, E. A. J. M. Schulten, and J. Klein-Nulend, “Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro,” Tissue Engineering—Part A, vol. 19, no. 3-4, pp. 571–581, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. E. M. Czekanska, J. R. Ralphs, M. Alini, and M. J. Stoddart, “Enhancing inflammatory and chemotactic signals to regulate bone regeneration,” European Cells & Materials, vol. 28, pp. 320–334, 2014. View at Google Scholar · View at Scopus
  25. J. J. Bara, R. G. Richards, M. Alini, and M. J. Stoddart, “Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic,” STEM CELLS, vol. 32, no. 7, pp. 1713–1723, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. B. Coelho, J. M. S. Cabral, and J. M. Karp, “Intraoperative stem cell therapy,” Annual Review of Biomedical Engineering, vol. 14, pp. 325–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. G. K. Handschel, R. A. Depprich, N. R. Kübler, H.-P. Wiesmann, M. Ommerborn, and U. Meyer, “Prospects of micromass culture technology in tissue engineering,” Head & Face Medicine, vol. 3, no. 1, article 4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Gerber and I. ap Gwynn, “Differentiation of rat osteoblast-like cells in monolayer and micromass cultures,” European Cells & Materials, vol. 3, pp. 19–30, 2002. View at Google Scholar · View at Scopus
  29. K. Jähn, R. G. Richards, C. W. Archer, and M. J. Stoddart, “Pellet culture model for human primary osteoblasts,” European Cells & Materials, vol. 20, pp. 149–161, 2010. View at Google Scholar · View at Scopus
  30. E. M. Czekanska, M. J. Stoddart, R. G. Richards, and J. S. Hayes, “In search of an osteoblast cell model for in vitro research,” European Cells & Materials, vol. 24, pp. 1–17, 2012. View at Google Scholar · View at Scopus
  31. M. Ilmer, M. Karow, C. Geissler, M. Jochum, and P. Neth, “Human osteoblast-derived factors induce early osteogenic markers in human mesenchymal stem cells,” Tissue Engineering Part A, vol. 15, no. 9, pp. 2397–2409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Czekanska, In vitro cell and culture models for osteoblass and their progenitors [Ph.D. thesis], School of Biosciences, Cardiff University, Cardiff, UK, 2014.
  33. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Labarca and K. Paigen, “A simple, rapid, and sensitive DNA assay procedure,” Analytical Biochemistry, vol. 102, no. 2, pp. 344–352, 1980. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Murakami, V. Lefebvre, and B. de Crombrugghe, “Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-α,” The Journal of Biological Chemistry, vol. 275, no. 5, pp. 3687–3692, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. Coelho and M. H. Fernandes, “Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, β-glycerophosphate and dexamethasone on osteoblastic differentiation,” Biomaterials, vol. 21, no. 11, pp. 1095–1102, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Dimitriou, E. Tsiridis, and P. V. Giannoudis, “Current concepts of molecular aspects of bone healing,” Injury, vol. 36, no. 12, pp. 1392–1404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. L. C. Gerstenfeld and T. A. Einhorn, “Developmental aspects of fracture healing and the use of pharmacological agents to alter healing,” Journal of Musculoskeletal & Neuronal Interactions, vol. 3, no. 4, pp. 297–303, 2003. View at Google Scholar · View at Scopus
  39. A. I. Hoch, B. Y. Binder, D. C. Genetos, and J. K. Leach, “Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells,” PLoS ONE, vol. 7, no. 4, Article ID e35579, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. Bara, H. E. McCarthy, E. Humphrey, W. E. B. Johnson, and S. Roberts, “Bone marrow-derived mesenchymal stem cells become antiangiogenic when chondrogenically or osteogenically differentiated: implications for bone and cartilage tissue engineering,” Tissue Engineering Part A, vol. 20, no. 1-2, pp. 147–159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Nakashima and B. de Crombrugghe, “Transcriptional mechanisms in osteoblast differentiation and bone formation,” Trends in Genetics, vol. 19, no. 8, pp. 458–466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Loebel, E. M. Czekanska, M. Bruderer, G. Salzmann, M. Alini, and M. J. Stoddart, “In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio,” Tissue Engineering—Part A, vol. 21, no. 1-2, pp. 115–123, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Wehling, G. D. Palmer, C. Pilapil et al., “Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways,” Arthritis and Rheumatism, vol. 60, no. 3, pp. 801–812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Lu, M. Ashraf, and K. H. Haider, “Insulin-like growth factor-1 preconditioning accentuates intrinsic survival mechanism in stem cells to resist ischemic injury by orchestrating protein kinase Cα-Erk1/2 activation,” Antioxidants & Redox Signaling, vol. 16, no. 3, pp. 217–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. B. Lian and G. S. Stein, “Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation,” The Iowa Orthopaedic Journal, vol. 15, pp. 118–140, 1995. View at Google Scholar · View at Scopus
  46. N. Jaiswal, S. E. Haynesworth, A. I. Caplan, and S. P. Bruder, “Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro,” Journal of Cellular Biochemistry, vol. 64, no. 2, pp. 295–312, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Gowen, D. D. Wood, and R. G. G. Russell, “Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity,” The Journal of Clinical Investigation, vol. 75, no. 4, pp. 1223–1229, 1985. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Huang, E. R. Nelson, R. L. Smith, and S. B. Goodman, “The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro,” Tissue Engineering, vol. 13, no. 9, pp. 2311–2320, 2007. View at Google Scholar
  49. J.-B. Park, “The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression,” The Journal of Surgical Research, vol. 173, no. 1, pp. 99–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. E. M. Czekanska, M. J. Stoddart, J. R. Ralphs, R. G. Richards, and J. S. Hayes, “A phenotypic comparison of osteoblast cell lines versus human primary osteoblasts for biomaterials testing,” Journal of Biomedical Materials Research Part A, vol. 102, no. 8, pp. 2636–2643, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Dedhar, “Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin-1 beta in human osteosarcoma cells: inhibition of cell proliferation and stimulation of alkaline phosphatase activity,” Journal of Cellular Physiology, vol. 138, no. 2, pp. 291–299, 1989. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Dedhar, M. D. Mitchell, and M. D. Pierschbacher, “The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties,” Connective Tissue Research, vol. 20, no. 1–4, pp. 49–61, 1989. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Raposo and W. Stoorvogel, “Extracellular vesicles: exosomes, microvesicles, and friends,” The Journal of Cell Biology, vol. 200, no. 4, pp. 373–383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. O. G. de Jong, B. W. M. van Balkom, R. M. Schiffelers, C. V. C. Bouten, and M. C. Verhaar, “Extracellular vesicles: potential roles in regenerative medicine,” Frontiers in Immunology, vol. 5, article 608, 2014. View at Publisher · View at Google Scholar · View at Scopus